findmyKOL
Clinical trialNCT00871195CompletedObservational

A Noninvasive Test for Fetal RHD Genotype

SponsorSequenom, Inc.Enrollment520Rhesus D Genotype
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this study is to evaluate the performance of Sequenom's noninvasive test for fetal RHD genotype. The test uses MALDI-TOF mass spectrometry to detect DNA. The study is specifically designed to determine whether RHD typing using free fetal DNA in maternal circulation can accurately predict the neonatal RhD phenotype at birth.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Canada
  • University of British Columbia

    Vancouver, British Columbia, Canada

  • Mt. Sinai School of Medicine

    Toronto, Ontario, Canada

  • Mcgill University

    Montreal, Quebec, Canada

United States
  • Obstetrix Medical Group of Phoenix

    Phoenix, Arizona, United States

  • Wayne State University

    Detroit, Michigan, United States

  • Columbia University

    New York, New York, United States

  • Mt. Sinai School of Medicine

    New York, New York, United States

  • University of North Carolina

    Chapel Hill, North Carolina, United States

  • Good Samaritan Hospital

    Cincinnati, Ohio, United States

  • Ohio State University

    Columbus, Ohio, United States

  • Thomas Jefferson

    Philadelphia, Pennsylvania, United States

  • Baylor College of Medicine

    Houston, Texas, United States

  • Evergreen Hospital

    Kirkland, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
30 Apr 2009
Primary completion
30 Nov 2011
Completion
30 Apr 2012
Last update posted
10 May 2012
Registered enrollment
520
Registry id
NCT00871195

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.